Semiquantitative Analysis of Apolipoprotein A‐I Modified by Advanced Glycation End Products in Diabetes Mellitus

BACKGROUND: Apolipoprotein A‐I (Apo A‐I), the major component of high‐density lipoprotein (HDL), is modified by reactive α‐oxoaldehydes, such as methylglyoxal (MG) and glycolaldehyde (GA), and these modifications affect the function of Apo A‐I. GA‐ and MG‐modified Apo A‐I serum levels were semiquant...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Lab Anal
Auteurs principaux: Kurosaki, Yoshifumi, Tsukushi, Tomoaki, Munekata, Shinichi, Akahoshi, Tohru, Moriya, Tatsumi, Ogawa, Zensuke
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2013
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6807556/
https://ncbi.nlm.nih.gov/pubmed/23440769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.21591
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires